FEATURED NEWS
NEWS: COMPARISON OF URIDINE AND N1-METHYLPSEUDOURIDINE mRNA PLATFORMS IN DEVELOPMENT OF AN ANDES VIRUS VACCINE (JUL 2024)
Congratulations to Jennifer Moon, co-author of a recent study featured in Nature Communications. She collaborated with scientists from the Departments of Microbiology and Immunology, Biochemistry and Molecular Biology, and Pathology at the University of Texas Medical Branch to study mRNA vaccines against the Andes virus. Click to read more info.
NEWS: THE ROLES OF CD4+ T CELL HELP, SEX, AND DOSE IN THE INDUCTION OF PROTECTIVE CD8+ T CELLS AGAINST A LETHAL POXVIRUS BY mRNA-LNP VACCINES (JUL 2024)
Congratulations to Ying Tam, co-author of a recent study featured in Molecular Therapy. He collaborated with scientists from Thomas Jefferson University and the Pardi Lab at the University of Pennsylvania Perelman School of Medicine, studying the role of CD4+ T cell help in CD8+ T cell responses to an mRNA-LNP vaccine’s effectiveness and design. Click to read more info.
NEWS: mRNA LIPID NANOPARTICLES EXPRESSING CELL-SURFACE CLEAVAGE INDEPENDENT HIV ENV TRIMERS ELICIT AUTOLOGOUS TIER-2 NEUTRALIZING ANTIBODIES (JUL 2024)
Congratulations to Ying Tam and Paulo Lin, co-authors of a recent study featured in Frontiers in Immunology. They collaborated with scientists from the Wyatt Lab, Department of Immunology and Microbiology, and the Weissman Lab, Penn Institute for RNA Innovation at the University of Pennsylvania Perelman School of Medicine, to generate HIV-1 neutralizing antibodies following immunization. Click to read more info.